Search - tctmd.com

Displaying 301 - 320 of 2668

Sort: Relevancy | Date

Presentation NY Valves 2024

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Presenter: Ramesh Daggubati

June 06, 2024

Presentation NY Valves 2024

Ascending Aortic Aneurysm Treated With Conformable Thoracic Stent Graft

Presenter: Muhammad Jafar Khan

June 06, 2024

Presentation NY Valves 2024

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

Presenter: Antonio Mangieri

June 06, 2024

Presentation NY Valves 2024

The 2024 'Toolbox' for Leaflet Modification in TAVR

Presenter: Jaffar M. Khan

June 06, 2024

Presentation NY Valves 2024

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

How to Interpret the Pathology Data From TAVR Explants

Presenter: Stephanie Sellers

June 06, 2024

Presentation NY Valves 2024

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

Presenter: Bernard Prendergast

June 06, 2024

Presentation NY Valves 2024

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

Presenter: Keith B. Allen

June 06, 2024

Presentation NY Valves 2024

TAVR in Young Patients - Current Treatment Patterns in the US

Presenter: Mayra Guerrero

June 06, 2024

Presentation NY Valves 2024

Transcatheter Valve Selection for Revalving and Overview of European Trials

Presenter: Radoslaw Parma

June 06, 2024

Presentation NY Valves 2024

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

The Coronary Access Conundrum in Revalving Strategies

Presenter: Giuseppe Tarantini

June 06, 2024

Presentation NY Valves 2024

Projecting the Frequency of Failed Transcatheter Aortic Valves

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

Surgery Following Transcatheter Mitral Procedures: Outcomes and Perspectives

Presenter: Vinay Badhwar

June 06, 2024

Presentation NY Valves 2024

TMVR Following Failed M-TEER: Technical and Procedural Considerations

Presenter: Rodrigo D. Estevez-Loureiro

June 06, 2024

Presentation NY Valves 2024

Bioprosthetic Valve Fracture for Mitral ViV Therapy: Indication, Technique and Outcomes

Presenter: John Thomas Saxon

June 06, 2024

Presentation NY Valves 2024

Pre-Emptive vs. Rescue LAMPOON in Mitral ViV and ViR Intervention: Indications and Technical Considerations

Presenter: Jaffar M. Khan

June 06, 2024

Presentation NY Valves 2024

Procedural Planning in Mitral Valve Re-Intervention: Size and Shape of Neo-LVOT Matters!

Presenter: Omar K. Khalique

June 06, 2024

Presentation NY Valves 2024

How I Assess a Patient for Mitral TEER With an Imaging Focused Perspective

Presenter: Rhonda Miyasaka

June 06, 2024

Presentation NY Valves 2024

Case Presentation 2: TAVR in Bicuspid AS with SEV

Presenter: John K. Forrest

June 05, 2024

Advertisement

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Ascending Aortic Aneurysm Treated With Conformable Thoracic Stent Graft

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

The 2024 'Toolbox' for Leaflet Modification in TAVR

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

How to Interpret the Pathology Data From TAVR Explants

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

TAVR in Young Patients - Current Treatment Patterns in the US

Transcatheter Valve Selection for Revalving and Overview of European Trials

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

The Coronary Access Conundrum in Revalving Strategies

Projecting the Frequency of Failed Transcatheter Aortic Valves

Surgery Following Transcatheter Mitral Procedures: Outcomes and Perspectives

TMVR Following Failed M-TEER: Technical and Procedural Considerations

Bioprosthetic Valve Fracture for Mitral ViV Therapy: Indication, Technique and Outcomes

Pre-Emptive vs. Rescue LAMPOON in Mitral ViV and ViR Intervention: Indications and Technical Considerations

Procedural Planning in Mitral Valve Re-Intervention: Size and Shape of Neo-LVOT Matters!

How I Assess a Patient for Mitral TEER With an Imaging Focused Perspective

Case Presentation 2: TAVR in Bicuspid AS with SEV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content